不同PSMA PET放射性连接体的膀活性和罗西米德的影响
Research square
|May 19, 2025
概括
这项研究比较了不同前列腺特异性膜抗原 (PSMA) 放射性对象的膀活性,用于前列腺癌 (PCa) 的PET成像. 富罗塞米德的使用显著降低了膀活动,改善了PCa成像中病变的检测.
科学领域:
- 核医学是一种核医学.
- 放射性药物科学 是一种放射性药物科学.
- 瘤学成像成像 瘤学成像
背景情况:
- 前列腺特异性膜抗原 (PSMA) 放射性对象对于前列腺癌 (PCa) 的PET成像至关重要.
- 这些放射性链体在尿液中的可变分泌导致膀活动高,可能会掩盖前列腺床中的疾病检测.
- 研究降低膀活动的方法对于提高PCa分期和监测的诊断准确性至关重要.
研究的目的:
- 为了比较分析PET成像中使用的各种PSMA放射性对象的膀活性.
- 为了评估furosemide在减少膀活动方面的疗效.
- 评估膀活动减少对前列腺癌患者病变检测的影响.
主要方法:
- 对210名前列腺癌患者的PSMA PET/CT扫描进行了回顾性分析.
- 膀活动 (SUVmean,SUVmax) 和体积在不同的放射性连接体之间的比较:F-PSMA-1007,F-rhPSMA-7.3,68Ga-PSMA-11,和F-DCFPyL.
- 评估furosemide对选定患者群体的膀活动和体积的影响.
主要成果:
- 在放射性连接体 (P < 0.001) 中观察到膀SUV平均值的显著变化,其中F-PSMA-1007显示的活性最低.
- 服用20毫克的富罗塞米德显著降低了膀活动 (例如,F-rhPSMA-7.3: 10.00 到 2.95; Ga-PSMA-11: 15.92 到 10.21) 和增加了膀体积 (P < 0.05).
- 在膀SUVmax和膀体积 (P = 0.008) 之间发现了显著的负相关性.
结论:
- 18F-PSMA-1007表现出膀活动最低,而F-DCFPyL和Ga-PSMA-11在评估的PSMA放射性连体中表现出最高.
- 富罗塞米德有效地降低了膀活动,并增加了膀体积,使F-rhPSMA-7.3的膀活动与F-PSMA-1007相比,当同时使用时.
- 这些发现表明,furosemide是通过减轻膀干扰来提高前列腺癌PSMA PET/CT成像质量的有价值的辅助剂.
更多相关视频
09:49A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
Published on: April 24, 2020
9.6K
09:5718F-Labeling of Radiotracers Functionalized with a Silicon Fluoride Acceptor SiFA for Positron Emission Tomography
Published on: January 11, 2020
7.3K
相关概念视频
Imaging Studies II: Positron Emission Tomography and Scintigraphy
63
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET
63
Positron Emission Tomography
3.9K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
3.9K
